The shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has been pegged with a rating of Sector Weight by KeyBanc Capital Markets in its latest research note that was published on February 22nd, 2019. KeyBanc Capital Markets wasn’t the only research firm that published a report of Allscripts Healthcare Solutions, Inc., with other equities research analysts also giving their opinion on the stock. Citigroup advised investors in its research note published on February 22nd, 2019, to Neutral the MDRX stock. The stock had earned Overweight rating from KeyBanc Capital Mkts when it published its report on January 18th, 2019. The stock was given Hold rating by Argus in its report released on November 14th, 2018. BofA/Merrill was of a view that MDRX is Buy in its latest report on November 2nd, 2018 while giving it a price target of $15. SunTrust thinks that MDRX is worth Hold rating. This was contained in the firm’s report on November 2nd, 2018.

Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 13 believe it has the potential for further growth, thus rating it as Hold while 5 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $12.00. The price of the stock the last time has raised by 22.60% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 57.64.

The shares of the company added by 0.87% during the trading session on Tuesday, reaching a low of $10.28 while ending the day at $10.47. During the trading session, a total of 1.55 million shares were traded which represents a 8.48% incline from the average session volume which is 1.69M shares. MDRX had ended its last session trading at 10.38. Allscripts Healthcare Solutions, Inc. currently has a market cap of $1.73B, while its P/E ratio stands at 59.83, while its P/E earnings growth sits at 0.99, with a beta of 1.21. Allscripts Healthcare Solutions, Inc. debt-to-equity ratio currently stands at 0.54, while its quick ratio hovers at 1.00. MDRX 52-week low price stands at $8.54 while its 52-week high price is $14.97.

The company in its last quarterly report recorded $0.16 earnings per share which is above the $0.14 predicted by most analysts. The Allscripts Healthcare Solutions, Inc. generated $432.60 million in revenue during the last quarter, which is slightly lower than the $436.50 million predicted by analysts. In the second quarter last year, the firm recorded $0.20 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -25%. Allscripts Healthcare Solutions, Inc. has the potential to record 0.18 EPS for the current fiscal year, according to equities analysts.

Investment analysts at Susquehanna published a research note on June 11th, 2019 where it informed investors and clients that Lyft, Inc. (NASDAQ:LYFT) is now rated as Positive. Their price target on the stock stands at $80. Citigroup also rated LYFT as Downgrade on February 22nd, 2019, with its price target of $32 suggesting that LYFT could surge by 20.68% from its current share price. Even though the stock has been trading at $56.76/share, analysts expect it to surge higher by 2.31% to reach $73.21/share. It started the day trading at $59.25 and traded between $56.31 and $58.07 throughout the trading session.

At the moment, only of Lyft, Inc. shares were sold short. The company’s average trading volume currently stands at 10.21M shares, which means that the short-interest ratio is just 2.04 days. Over the past seven days, the company moved, with its shift of -1.86%. Looking further, the stock has dropped over the past 90 days while it lost over the last six months.